Sign In
Buy LRMR
$4.11
+0.130 (+3.27%)
At Close: Aug 04, 2026
Why Larimar (LRMR) Might Surprise This Earnings Season
10:04am, Monday, 09'th Aug 2021
Larimar (LRMR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Larimar Therapeutics to Present at the JMP Securities Life Sciences Conference
07:00am, Friday, 11'th Jun 2021
BALA CYNWYD, Pa., June 11, 2021 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR
07:55pm, Saturday, 05'th Jun 2021
New York, New York--(Newsfile Corp. - June 5, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Larimar Therapeutics, Inc. ("Larimar" or the "Company") (NASDAQ: LRMR). Such inves
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR
04:55am, Tuesday, 01'st Jun 2021
NEW YORK, June 1, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Larimar Therapeutics, Inc. ("Larimar" or the "Company") (NASDAQ: LRMR). Such investors are
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR
10:59pm, Saturday, 29'th May 2021
New York, New York--(Newsfile Corp. - May 29, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Larimar Therapeutics, Inc. ("Larimar" or the "Company") (NASDAQ: LRMR). Such inves
Larimar Therapeutics Reports FDA Clinical Hold on CTI-1601 and Termination of Recently Announced Private Placement Financing
05:41pm, Tuesday, 25'th May 2021
BALA CYNWYD, Pa., May 25, 2021 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for Friedreich's a
Larimar Shares Trade Higher On $95M Capital Raise, CTI-1601's Priority Medicines Tag In Europe
03:47pm, Friday, 21'st May 2021
Larimar Therapeutics Inc (NASDAQ: LRMR) has executed a securities purchase agreement to raise gross proceeds of approximately $95 million in a private placement. The proceeds will be used to suppor
Larimar Therapeutics Announces $95 Million Private Placement Financing
09:18am, Friday, 21'st May 2021
BALA CYNWYD, Pa., May 21, 2021 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for Friedreich's a
Larimar Therapeutics Receives European Medicines Agency Priority Medicines (PRIME) Designation for CTI-1601 in Friedreich's Ataxia
04:31pm, Thursday, 20'th May 2021
BALA CYNWYD, Pa., May 20, 2021 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for Friedreich's a
Why Is Larimar Therapeutics Stock Plunging Despite Positive CTI-1601 Data?
03:35pm, Tuesday, 11'th May 2021
Larimar Therapeutics Inc (NASDAQ: LRMR) shares are trading lower despite announcing positive topline data from its Phase 1 multiple ascending dose trial evaluating CTI-1601 as a treatment for Frie
12 Healthcare Stocks Moving In Thursday's After-Market Session
12:00am, Thursday, 22'nd Oct 2020
Gainers
Cassava Sciences (NASDAQ:SAVA) stock rose 20.61% to $10.65 during Thursday's after-market session. Today's trading volume for this security ended up closing at 271...
Major U.S. Retail Chain Selects 3CLogic to Modernize Customer Service
12:00am, Tuesday, 20'th Oct 2020
A major U.S. retail chain selected 3CLogic's Cloud Call Center solution for ServiceNow ITSM and CSM to modernize its customer service initiatives.
State-Sponsored Hackers and Ransomware Gangs Are Diversifying Tactics to Inflict More Harm, According to Accenture Report
12:00am, Monday, 19'th Oct 2020
State-sponsored hackers and ransomware gangs are diversifying tactics to inflict more harm, says Accenture.
Galapagos Knee Osteoarthritis Data, And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:GLPG)
10:18am, Sunday, 18'th Oct 2020
Galapagos announces topline data from knee osteoarthritis trial. Evelo provides updates for EDP1815 in Atopic Dermatitis and Psoriasis trials.
12 Healthcare Stocks Moving In Tuesday's After-Market Session
12:00am, Tuesday, 06'th Oct 2020
Gainers
Integra Lifesciences (NASDAQ:IART) stock surged 6.33% to $51.9 during Tuesday's after-market session. This security traded at a volume of 11.8K shares come close,...
